Dimensional Fund Advisors LP Harvard Bioscience Inc Transaction History

Dimensional Fund Advisors LP

  • $449 Billion
  • Q3 2025

A detailed history of Dimensional Fund Advisors LP transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 496,144 shares of HBIO stock, worth $322,493. This represents 0.0% of its overall portfolio holdings.

Number of Shares
496,144
Previous 1,126,250 55.95%
Holding current value
$322,493
Previous $495,000 56.97%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
SELL
$0.4 - $0.57 $252,042 - $359,160
-630,106 Reduced 55.95%
496,144 $213,000
Q2 2025

Aug 12, 2025
SELL
$0.28 - $0.69 $87,236 - $214,975
-311,558 Reduced 21.67%
1,126,250 $495,000
Q1 2025

May 13, 2025
SELL
$0.57 - $2.19 $129,563 - $497,797
-227,305 Reduced 13.65%
1,437,808 $819,000
Q4 2024

Feb 13, 2025
SELL
$2.02 - $2.82 $102,547 - $143,160
-50,766 Reduced 2.96%
1,665,113 $3.51 Million
Q3 2024

Nov 07, 2024
SELL
$2.64 - $3.54 $295,070 - $395,662
-111,769 Reduced 6.12%
1,715,879 $4.62 Million
Q2 2024

Aug 09, 2024
SELL
$2.77 - $4.63 $273,338 - $456,879
-98,678 Reduced 5.12%
1,827,648 $5.21 Million
Q1 2024

May 10, 2024
BUY
$4.02 - $5.39 $2,777 - $3,724
691 Added 0.04%
1,926,326 $8.17 Million
Q4 2023

Feb 07, 2024
SELL
$4.0 - $5.49 $33,324 - $45,737
-8,331 Reduced 0.43%
1,925,635 $10.3 Million
Q3 2023

Nov 09, 2023
BUY
$4.0 - $5.82 $465,348 - $677,081
116,337 Added 6.4%
1,933,966 $8.32 Million
Q2 2023

Aug 09, 2023
BUY
$4.19 - $6.16 $303,758 - $446,575
72,496 Added 4.15%
1,817,629 $9.98 Million
Q1 2023

May 12, 2023
BUY
$2.45 - $4.22 $9,763 - $16,816
3,985 Added 0.23%
1,745,133 $7.33 Million
Q4 2022

Feb 09, 2023
SELL
$2.12 - $2.86 $2,694 - $3,635
-1,271 Reduced 0.07%
1,741,148 $4.82 Million
Q3 2022

Nov 10, 2022
SELL
$2.33 - $3.92 $315,535 - $530,858
-135,423 Reduced 7.21%
1,742,419 $4.46 Million
Q2 2022

Aug 12, 2022
SELL
$3.28 - $6.42 $682 - $1,335
-208 Reduced 0.01%
1,877,842 $6.76 Million
Q1 2022

May 13, 2022
SELL
$5.16 - $7.14 $28,627 - $39,612
-5,548 Reduced 0.29%
1,878,050 $11.7 Million
Q4 2021

Feb 09, 2022
SELL
$6.37 - $8.18 $523,747 - $672,567
-82,221 Reduced 4.18%
1,883,598 $13.3 Million
Q3 2021

Nov 12, 2021
BUY
$6.98 - $8.47 $71,817 - $87,147
10,289 Added 0.53%
1,965,819 $13.7 Million
Q2 2021

Aug 12, 2021
SELL
$5.44 - $8.4 $105,465 - $162,850
-19,387 Reduced 0.98%
1,955,530 $16.3 Million
Q1 2021

May 14, 2021
SELL
$3.91 - $6.99 $203,609 - $363,997
-52,074 Reduced 2.57%
1,974,917 $10.8 Million
Q4 2020

Feb 25, 2021
BUY
$3.0 - $4.5 $6.08 Million - $9.12 Million
2,026,991 New
2,026,991 $8.7 Million

Others Institutions Holding HBIO

# of Institutions
65
Shares Held
19.5M
Call Options Held
54K
Put Options Held
0
View Full List

About HARVARD BIOSCIENCE INC

HBIO Quotes by TradingView
  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $27.1M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email